WebMar 24, 2024 · Cosacthen contains 0.25 mg/ml of tetracosactide which had only previously been available as human-registered or compounded veterinary ‘special’ preparations … WebApr 11, 2024 · Cosacthen® contains 0.25 mg/ml of tetracosactide which had only previously been available as human-registered or compounded veterinary ‘special’ …
Packungsbeilage - English translation – Linguee
WebDuration. 2 - 5 days. Assessment. Corresponds to the basic ACTH Stimulation Test regarding the interpretation of cortisol. To clarify steroidal adrenal pathologies, cortisol and 17-OHprogesterone can be determined simultaneously. This is also possible in case of questionable results when determining the cortisol level after ACTH stimulation. WebPackungsbeilage oder das Etikett vorzuzeigen. 4.6 Nebenwirkungen (Häufigkeit und Schwere): Erbrechen wurde häufig in klinischen Studien beobachtet. Gelegentlich wurden Blutergüsse (nach intramuskulärer Anwendung) bzw. Hämatome (nach intravenöser Anwendung) an der Applikationsstelle, Depression, Durchfall, Lahmheit und Nervosität the cycle heavy construction part 5
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
WebFeb 28, 2024 · Cosacthen Dosage And Administration The dose is 0.25 mg (1 mL) per dog weighing 4.5-50 kg, administered by intravenous or intramuscular injection, with the … WebDec 16, 2024 · Cosacthen 0.25 mg/ml Solution for Injection for Dogs MA holder Dechra Limited VM number 10434/4099 Territory Northern Ireland Aligned product View aligned product details. Associated documents View Summary of Product Characteristics; View Product Literature (labelling and package leaflet text) ... WebCosacthen est une solution aqueuse claire. Chaque millilitre renferme 0,25 mg de tétracosactide. Les ingrédients non-médicinaux sont 1 mg d’acide acétique glacial, 0,82 … the cycle how many players